KRRO
Price:
$6.81
Market Cap:
$63.86M
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Industry
Biotechnology
IPO Date
2019-10-03
Stock Exchange
NASDAQ
Ticker
KRRO
According to Korro Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 74.88M. This represents a change of -66.38% compared to the average of 222.74M of the last 4 quarters.
The mean historical Enterprise Value of Korro Bio, Inc. over the last ten years is 452.95M. The current 74.88M Enterprise Value has changed 1.55% with respect to the historical average. Over the past ten years (40 quarters), KRRO's Enterprise Value was at its highest in in the December 2022 quarter at 1.03B. The Enterprise Value was at its lowest in in the June 2022 quarter at 54.78M.
Average
452.95M
Median
399.43M
Minimum
-57807940.00
Maximum
1.10B
Discovering the peaks and valleys of Korro Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 182.75%
Maximum Annual Enterprise Value = 1.10B
Minimum Annual Increase = -668.66%
Minimum Annual Enterprise Value = -57807940.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 328.73M | -668.66% |
| 2023 | -57807940.00 | -463.93% |
| 2022 | 15.88M | -98.56% |
| 2021 | 1.10B | 14.52% |
| 2020 | 962.90M | 182.75% |
| 2019 | 340.55M | -27.90% |
| 2018 | 472.30M | 3.05% |
The current Enterprise Value of Korro Bio, Inc. (KRRO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
95.60M
5-year avg
470.49M
10-year avg
452.95M
Korro Bio, Inc.’s Enterprise Value is less than enGene Holdings Inc. (396.46M), less than Altimmune, Inc. (407.41M), less than Annexon, Inc. (432.32M), less than DBV Technologies S.A. (361.46M), less than Larimar Therapeutics, Inc. (299.00M), less than Amarin Corporation plc (224.37M), less than Silence Therapeutics plc (254.57M), less than Alto Neuroscience, Inc. (272.30M), less than Aura Biosciences, Inc. (320.33M), less than LB Pharmaceuticals Inc Common Stock (467.73M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 396.46M | $420.82M | |
| 407.41M | $468.65M | |
| 432.32M | $536.98M | |
| 361.46M | $312.18M | |
| 299.00M | $314.97M | |
| 224.37M | $340.44M | |
| 254.57M | $336.78M | |
| 272.30M | $415.67M | |
| 320.33M | $409.59M | |
| 467.73M | $487.01M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Korro Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Korro Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Korro Bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Korro Bio, Inc. (KRRO)?
What is the 3-year average Enterprise Value for Korro Bio, Inc. (KRRO)?
What is the 5-year average Enterprise Value for Korro Bio, Inc. (KRRO)?
How does the current Enterprise Value for Korro Bio, Inc. (KRRO) compare to its historical average?